Cerapedics announces Canadian OK of its next-generation bone graft 

Cerapedics announces Canadian OK of its next-generation bone graft 

WESTMINSTER -- Cerapedics, a private ortho-biologics company, today announced Health Canada approval of the company's next-generation bone graft called i-FACTOR+ Matrix, making it the first market... Read More

Tuesday September 15, 2020 0 comments Tags: Westminster, Cerapedics, Glen Kashuba, Jeffrey Marx, i-FACTOR+Matrix

Cerapedics: FDA approves company's IDE supplement

Cerapedics: FDA approves company's IDE supplement

WESTMINSTER -- Cerapedics announced the U.S. Food and Drug Administration (FDA) has approved the company's Investigational Device Exemption (IDE) supplement, reducing the enrollment requirement for... Read More

Friday July 24, 2020 0 comments Tags: Westminster, Cerapedics, Jeffrey Marx, Glen Kashuba

Cerapedics announces FDA approval of PMA supplement based on two-year clinical data

Cerapedics announces FDA approval of PMA supplement based on two-year clinical data

WESTMINSTER -- Cerapedics, a private ortho-biologics company, announced the U.S. Food and Drug Administration (FDA) has approved the company's Premarket Approval (PMA) supplement for i-FACTOR... Read More

Tuesday November 19, 2019 0 comments Tags: Westminster, Cerapedics, Jeffrey Marx, Glen Kashuba

Cerapedics to expand Colorado HQ, more than double workforce

Cerapedics to expand Colorado HQ, more than double workforce

WESTMINSTER -- Cerapedics , a private ortho-biologics company, announced the expansion of the company's headquarters in theDenvermetropolitan area. Over the past 18 months, Cerapedics has... Read More

Tuesday July 9, 2019 0 comments Tags: Westminster, Cerapedics, Glen Kashuba, Edward Sawyer

Cerapedics announces first patients enrolled in IDE clinical trial of P-15L Bone Graft for TLIF surgery

Cerapedics announces first patients enrolled in IDE clinical trial of P-15L Bone Graft for TLIF surgery

WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, today announced the first patients have been enrolled in an investigational device exemption (IDE) clinical trial evaluating... Read More

Tuesday July 31, 2018 0 comments Tags: Westminster, Cerapedics, Glen Kashuba, P-15L Peptide Enhanced Bone Graft

Cerapedics announces closing of $22M financing round led by KCK Group

Cerapedics announces closing of $22M financing round led by KCK Group

WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, announced the company completed a $22 million financing led by KCK Group, a family investment fund that focuses on innovative... Read More

Monday July 16, 2018 0 comments Tags: Westminster, Cerapedics, KCK Group, Glen Kashuba

 Cerapedics announces positive results of IVANOS bone graft study

Cerapedics announces positive results of IVANOS bone graft study

WESTMINSTER -- Cerapedics, a privately-held orthobiologics company, today announced results from the IVANOS study evaluating i-FACTOR Peptide Enhanced Bone Graft in lumbar posterolateral spine... Read More

Monday May 21, 2018 0 comments Tags: Westminster, Cerapedics, i-FACTOR, Glen Kashuba

Cerapedics appoints Doug Kohrs to board and names Antony Koblish chair

Cerapedics appoints Doug Kohrs to board and names Antony Koblish chair

WESTMINSTER -- Cerapedics , a privately-held orthobiologics company, announced the appointment of Doug Kohrs to the company's board of directors and the appointment of Antony Koblish as board... Read More

Wednesday October 25, 2017 0 comments Tags: Westminster, Cerapedics, Doug Kohrs, Antony Koblish, Glen Kashuba